R and D treatement IFRS v GAAP

My understanding is:

IFRS, research is expensed as incurred, development can be capitalized once technological feasibility has been established.

Gaap, research and development is expensed as incurred.

Do I have it down?


I would just point out one thing. For IFRS , I am not sure the extent CFAI goes into (it’s been a while), but to capitalize development expense, you have to meet more than just technological feasibility, you also need to be able to demonstrate ALL of the following, intention to complete with adequate resources allocated for completion ability to use or sell the asset how the asset would generate profits ability to measure the expense attributed to the development process